光谱探测器CT碘定量在血管与肾血池的个体内一致性
回顾性纳入79例接受两次或三次腹部双期光谱探测器CT扫描的患者,在腹主动脉、下腔静脉、门静脉和肾皮质测量常规图像CT值与碘浓度,发现静脉期测量的个体内纵向变异显著低于动脉期,静脉期图像更适合用于碘定量。
要点
- 静脉期碘定量个体内变异小于动脉期,阅片定量时优先选用静脉期图像。
- 动脉期肾皮质碘浓度测量变异最大,报告时需谨慎。
- 纵向随访比较碘浓度时,应意识到存在个体内生理性变异。
核心结论
- 不同时间点血管与肾皮质血池的个体内碘定量在静脉期图像最准确,动脉期测量变异更大。
研究设计与样本
- 回顾性纳入79例有两次(n=53)或三次(n=26)临床指征腹部双期光谱探测器CT扫描的患者。
- 由一名经验丰富的放射科医生在腹主动脉、下腔静脉、门静脉和肾皮质各放置两个ROI,测量常规图像CT值与碘浓度。
- 计算改良变异系数(MVC)评估不同时间点间的个体内纵向变异。
诊断标准与关键数值
- CT值与碘浓度测量的变异在静脉期显著低于动脉期(CT值:动脉期-4.2 vs 静脉期0.4;碘浓度:动脉期-3.9 vs 静脉期1.0;p≤0.05)。
- 动脉期常规图像CT值中位MVC:腹主动脉-1.8(-20.5至21.3)%,肾皮质-6.5(-44.0至25.0)%。
- 门静脉期常规图像CT值中位MVC:腹主动脉0.62(-11.1至11.7)%,肾皮质-1.6(-16.2至10.6)%。
- 动脉期碘浓度中位MVC:腹主动脉-2.5(-22.9至28.4)%,肾皮质-5.8(-55.9至29.6)%。
- 门静脉期碘浓度中位MVC:腹主动脉-0.7(-17.9至16.9)%,肾皮质-2.6(-17.6至12.5)%。
临床应用与阅片要点
- 静脉期图像应优先用于最小化个体内变异。
- 考虑将碘测量用于临床决策时需谨慎,尤其在肿瘤初始或随访影像背景下。
- 原文指出双能量CT碘图测量存在个体内生理性变异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The objective of this study was to evaluate the intra-individual, longitudinal consistency of iodine measurements regarding the vascular and renal blood pool in patients that underwent repetitive spectral detector computed tomography (SDCT) examinations to evaluate their utility for oncologic imaging.
METHODS: Seventy-nine patients with two (n = 53) or three (n = 26) clinically indicated biphasic SDCT scans of the abdomen were retrospectively included. ROI-based measurements of Hounsfield unit (HU) attenuation in conventional images and iodine concentration were performed by an experienced radiologist in the following regions (two ROIs each): abdominal aorta, vena cava inferior, portal vein, and renal cortices. Modified variation coefficients (MVCs) were computed to assess intra-individual longitudinal between the different time points.
RESULTS: Variation of HU attenuation and iodine concentration measurements was significantly lower in the venous than in the arterial phase images (attenuation/iodine concentration: arterial - 4.2/- 3.9, venous 0.4/1.0; p ≤ 0.05). Regarding attenuation in conventional images of the arterial phase, the median MVC was - 1.8 (- 20.5-21.3) % within the aorta and - 6.5 (- 44.0-25.0) % within the renal cortex while in the portal venous phase, it was 0.62 (- 11.1-11.7) % and - 1.6 (- 16.2-10.6) %, respectively. Regarding iodine concentration, MVC for arterial phase was - 2.5 (- 22.9-28.4) % within the aorta and - 5.8 (- 55.9-29.6) % within the renal cortex. The referring MVCs of the portal venous phase were - 0.7 (- 17.9-16.9) % and - 2.6 (- 17.6-12.5) %.
CONCLUSIONS: Intra-individual iodine quantification of the vascular and cortical renal blood pool at different time points works most accurately in venous phase images whereas measurements conducted in arterial phase images underlay greater variability.
KEY POINTS: • There is an intra-individual, physiological variation in iodine map measurements from dual-energy computed tomography. • This variation is smaller in venous phase examinations compared with arterial phase and therefore venous phase images should be preferred to minimize this intra-individual variation. • Care has to be taken, when considering iodine measurements for clinical decision-making, particularly in the context of oncologic initial or follow-up imaging.
引用
- Lennartz S, Abdullayev N, Zopfs D, et al. Intra-individual consistency of spectral detector CT-enabled iodine quantification of the vascular and renal blood pool. Eur Radiol. 2019. PMID: 31175416. doi:10.1007/s00330-019-06266-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。